Andrew Simmons

4PUBLICATIONS
38CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 25, 2024
Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP Inhibitors.

Jonathan Chou, Troy M Robinson, Emily A Egusa

|Oct 02, 2021
Response to Rucaparib in BRCA-Mutant Metastatic Castration-Resistant Prostate Cancer Identified by Genomic Testing in the TRITON2 Study.

Andrea Loehr, Akash Patnaik, David Campbell

|Feb 09, 2021
Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms.

Hanna Tukachinsky, Russell W Madison, Jon H Chung

|Feb 23, 2020
Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study.

Wassim Abida, David Campbell, Akash Patnaik

Pageof 1